AbbVie Inc
For the period ended Dec 31, 2024. Filed Feb 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 14, 2025
ABBV$293.30+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| as of December 31 (in millions, except share data) | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and equivalents | $5,524 | $12,814 |
| Short-term investments | 31 | 2 |
| Accounts receivable, net | 10,919 | 11,155 |
| Inventories | 4,181 | 4,099 |
| Prepaid expenses and other | 4,927 | 4,932 |
| Total current assets | 25,582 | 33,002 |
| Investments | 279 | 304 |
| Property and equipment, net | 5,134 | 4,989 |
| Intangible assets, net | 60,068 | 55,610 |
| Goodwill | 34,956 | 32,293 |
| Other assets | 9,142 | 8,513 |
| Total assets | $135,161 | $134,711 |
| Liabilities and Equity | ||
| Current liabilities | ||
| Current portion of long-term debt and finance lease obligations | $6,804 | $7,191 |
| Accounts payable and accrued liabilities | 31,945 | 30,650 |
| Total current liabilities | 38,749 | 37,841 |
| Long-term debt and finance lease obligations | 60,340 | 52,194 |
| Deferred income taxes | 2,579 | 1,952 |
| Other long-term liabilities | 30,129 | 32,327 |
| Commitments and contingencies | ||
| Stockholders' equity | ||
| Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,831,594,494 shares issued as of December 31, 2024 and 1,823,046,087 as of December 31, 2023 | 18 | 18 |
| Common stock held in treasury, at cost, 66,337,508 shares as of December 31, 2024 and 57,105,354 as of December 31, 2023 | (8,201) | (6,533) |
| Additional paid-in capital | 21,333 | 20,180 |
| Accumulated deficit | (7,900) | (1,000) |
| Accumulated other comprehensive loss | (1,925) | (2,305) |
| Total stockholders' equity | 3,325 | 10,360 |
| Noncontrolling interest | 39 | 37 |
| Total equity | 3,364 | 10,397 |
| Total liabilities and equity | $135,161 | $134,711 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.